Share:
Taro Pharmaceuticals USA Inc., Sandoz Inc., and Apotex Corporation – manufacturers of generic pharmaceuticals – have agreed to pay a total of nearly $450 million to settle allegations of price fixing, which resulted in higher prices for federal health programs and their beneficiaries. From 2013 to 2015, they allegedly paid and received compensation prohibited by the Anti-Kickback Statute through arrangements on price, supply, and allocation of customers with other manufacturers for drugs they manufactured. Taro will pay $213.2 million, Sandoz will pay $185 million, and Apotex will pay $49 million.
Source:
- Department of Justice: Pharmaceutical Companies Pay Over $400 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drugs
Share:
